is tirzepatide a glp 1 drug Study flags need to monitor frailty risks with GLP-1 drugs for older adults Tirzepatide vs Semaglutide | Understanding
Description
Factors such as adherence to the medication, individual metabolism, and lifestyle choices all influence the timeline for visible results

Discussion While the overall number of GLP-1 RA exposures increased during the study period, outcomes were largely benign, with the most common being no effect
doi: 10.2337/dc25-S009 52 LongBPelletierJKoyfmanABridwellRE

For detailed control analyses of the Baseline and Vehicle conditions, see Control analyses of Vehicle and Baseline data section of the Supplementary Results

Based on a sensitivity analysis with a maximum 5-year follow-up time, exposure misclassification introduced by long follow-up times might explain only partly this null association
